InvestorsHub Logo
icon url

nferna

07/26/22 10:28 PM

#15597 RE: greggors #15596

It seems to rest largely on the assertion of Dr. James Tumlin that the better efficacy observed in the low dose arm of the AURA LV trial as compared to the high dose arm was unexpected and non-obvious.

You can read all about it here:

https://developer.uspto.gov/ptab-web/#/search/documents?proceedingNumber=IPR2022-00617
icon url

Jesspro

07/26/22 11:08 PM

#15598 RE: greggors #15596

Are the patent lawyers/officials from both Aurinia and USPTO stupid to grant a patent that which is unpatentable?